The biochemical basis for growth inhibition by L‐phenylalanine in Neisseria gonorrhoeae

Authors:

Abstract
Summary: Clinical isolates of Neisseria gonorrhoeae are commonly subject to growth inhibition by phenylpyruvate or by L‐phenylalanine. A blockade of tyrosine biosynthesis is indicated since inhibition is reversed by either L‐tyrosine or 4‐hydroxyphenylpyruvate. Phenylalanine‐resistant (PheR) and phenylalanine‐sensitive (Phes) isolates both have a single 3‐deoxy‐D‐arabino‐heptulosonate 7‐phosphate (DAHP) synthase that is partially inhibited by L‐phenylalanine (80%). However, PheS and PheR isolates differ in that the ratio of phenylpyruvate aminotransferase to 4‐hydroxyphenylpyruvate aminotransferase is distinctly greater in PheS isolates than in PheR isolates. A mechanism for growth inhibition is proposed in which phenylalanine exerts two interactive effects, (i) Phenylalanine decreases precursor flow to 4‐hydroxyphenylpyruvate through its controlling effect upon DAHP synthase; and (ii) phenylalanine is largely transaminated to phenylpyruvate, which saturates both aminotransferases, preventing transamination of an already limited supply of 4‐hydroxyphenylpyruvate to L‐tyrosine.

This publication has 13 references indexed in Scilit: